METHYLPREDNISOLONE for Relapsing-remitting multiple sclerosis: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 148 adverse event reports in the FDA FAERS database where METHYLPREDNISOLONE was used for Relapsing-remitting multiple sclerosis.
Most Reported Side Effects for METHYLPREDNISOLONE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 10,364 | 16.2% | 2,842 | 4,839 |
| Drug ineffective | 9,959 | 15.6% | 2,776 | 4,831 |
| Product use in unapproved indication | 4,115 | 6.4% | 1,482 | 1,619 |
| Condition aggravated | 3,784 | 5.9% | 1,548 | 2,136 |
| Headache | 3,419 | 5.4% | 1,128 | 1,653 |
| Fatigue | 3,250 | 5.1% | 1,192 | 1,622 |
| Pyrexia | 3,226 | 5.1% | 998 | 2,014 |
| Pain | 3,165 | 5.0% | 1,348 | 1,532 |
| Nausea | 3,105 | 4.9% | 989 | 1,793 |
| Pneumonia | 3,006 | 4.7% | 1,598 | 1,933 |
| Rash | 3,005 | 4.7% | 1,367 | 1,511 |
| Hypertension | 2,801 | 4.4% | 1,372 | 1,378 |
| Diarrhoea | 2,684 | 4.2% | 1,199 | 1,648 |
| Dyspnoea | 2,592 | 4.1% | 942 | 1,568 |
| Rheumatoid arthritis | 2,381 | 3.7% | 1,301 | 1,227 |
Other Indications for METHYLPREDNISOLONE
Product used for unknown indication (9,568)
Immunosuppressant drug therapy (5,162)
Premedication (2,339)
Immunosuppression (2,041)
Covid-19 (1,633)
Rheumatoid arthritis (1,298)
Prophylaxis against transplant rejection (1,274)
Systemic lupus erythematosus (1,135)
Renal transplant (1,090)
Acute lymphocytic leukaemia (1,022)
Other Drugs Used for Relapsing-remitting multiple sclerosis
OCRELIZUMAB (15,658)
FINGOLIMOD (8,814)
OFATUMUMAB (3,864)
DIMETHYL (3,638)
NATALIZUMAB (2,749)
INTERFERON BETA-1A (2,058)
GLATIRAMER (1,965)
ALEMTUZUMAB (1,604)
TERIFLUNOMIDE (1,320)
RITUXIMAB (956)